Stock Events

Biomerieux 

€102.85
38
+€0.25+0.24% Today

Statistics

Day High
103.55
Day Low
102.6
52W High
106
52W Low
84.54
Volume
12,026
Avg. Volume
80,458
Mkt Cap
12.12B
P/E Ratio
31.19
Dividend Yield
0.82%
Dividend
0.84

Upcoming

Dividends

0.82%Dividend Yield
10Y Growth
7.21%
5Y Growth
18.19%
3Y Growth
6.42%
1Y Growth
N/A

Earnings

6MarExpected
Q2 2022
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Next
0
0.74
1.48
2.22
Expected EPS
N/A
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BIM.PA. It's not an investment recommendation.

About

bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries. It also provides a suite of software products and services that collect, analyze, and merge various sources of data to make decisions under the BIOMÉRIEUX VISION SUITE name; designs, manufactures, and maintains instruments and software; and designs and manufactures reagents for in vitro diagnostic tests. The company serves clinical and hospital laboratories, physicians, blood banks, vets, and industrial control laboratories. bioMérieux S.A. was formerly known as B-D Mérieux. The company was founded in 1963 and is headquartered in Marcy l'Etoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.
Show more...
CEO
Mr. Alexandre Merieux
Employees
12557
Country
FR
ISIN
FR0013280286
WKN
000A2DXZH

Listings